These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Dormond M; Gutierrez RL; Porter CK Trop Dis Travel Med Vaccines; 2016; 2():17. PubMed ID: 28883961 [TBL] [Abstract][Full Text] [Related]
84. [Thoughts on the "Management of Functional Dyspepsia and Irritable Bowel Syndrome in Practice"]. Kiss A Praxis (Bern 1994); 2023 Apr; 112(5-6):287. PubMed ID: 37042401 [No Abstract] [Full Text] [Related]
86. Dual histamine blockade for the treatment of adult functional dyspepsia: a single centre experience. Potter MDE; Goodsall TM; Walker MM; Talley NJ Gut; 2020 May; 69(5):966. PubMed ID: 31040169 [No Abstract] [Full Text] [Related]
88. Regulation of cholecystokinin secretion in humans. Liddle RA J Gastroenterol; 2000; 35(3):181-7. PubMed ID: 10755686 [No Abstract] [Full Text] [Related]
89. Can Ultrasonographic Measurements of Gastric Motility Identify Pathophysiological Abnormalities of Functional Dyspepsia and Irritable Bowel Syndrome? Lee HS J Neurogastroenterol Motil; 2020 Jan; 26(1):1-3. PubMed ID: 31917911 [No Abstract] [Full Text] [Related]
90. Is There Enough Evidence for the Association of GNβ3 C825T Polymorphism With Functional Dyspepsia and Irritable Bowel Syndrome? Park MI J Neurogastroenterol Motil; 2012 Jul; 18(3):348-9. PubMed ID: 22837889 [No Abstract] [Full Text] [Related]
91. Is There Enough Evidence for the Association of GNβ3 C825T Polymorphism With Functional Dyspepsia and Irritable Bowel Syndrome?: Author's Reply. Lee KJ J Neurogastroenterol Motil; 2012 Jul; 18(3):350-1. PubMed ID: 22837890 [No Abstract] [Full Text] [Related]
92. Effect of Wang C; Wang B; Aili M; Huo S; Han MT; Aibai S; Li ZJ Evid Based Complement Alternat Med; 2020; 2020():2528617. PubMed ID: 33281909 [No Abstract] [Full Text] [Related]
93. An orally administered magnoloside A ameliorates functional dyspepsia by modulating brain-gut peptides and gut microbiota. Xue Z; Wu C; Wei J; Xian M; Wang T; Yang B; Chen M Life Sci; 2019 Sep; 233():116749. PubMed ID: 31412264 [TBL] [Abstract][Full Text] [Related]
94. Child compound Endothelium corneum attenuates gastrointestinal dysmotility through regulating the homeostasis of brain-gut-microbiota axis in functional dyspepsia rats. He Y; Yang C; Wang P; Yang L; Wu H; Liu H; Qi M; Guo Z; Li J; Shi H; Wu X; Hu Z J Ethnopharmacol; 2019 Aug; 240():111953. PubMed ID: 31082513 [TBL] [Abstract][Full Text] [Related]
96. Contribution of sex and gender roles to the incidence of post-infectious irritable bowel syndrome in a prospective study. Park JH; Kang SH; Kim JS; Moon HS; Sung JK; Jeong HY Sci Rep; 2023 Nov; 13(1):19467. PubMed ID: 37945663 [TBL] [Abstract][Full Text] [Related]
97. Long-lasting dyspeptic symptoms - another consequence of the COVID-19 pandemic? Nazarewska A; Lewandowski K; Kaniewska M; Tulewicz-Marti E; Więcek M; Szwarc P; Rosołowski M; Marlicz W; Rydzewska G Prz Gastroenterol; 2023; 18(2):175-182. PubMed ID: 37538287 [TBL] [Abstract][Full Text] [Related]
98. Intestinal pseudo-obstruction caused by Pessarelli T; Basilisco G; Spina L; Fraquelli M BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36323453 [TBL] [Abstract][Full Text] [Related]
99. Gut Non-Bacterial Microbiota: Emerging Link to Irritable Bowel Syndrome. Liu A; Gao W; Zhu Y; Hou X; Chu H Toxins (Basel); 2022 Aug; 14(9):. PubMed ID: 36136534 [TBL] [Abstract][Full Text] [Related]
100. Enterochromaffin Cells-Gut Microbiota Crosstalk: Underpinning the Symptoms, Pathogenesis, and Pharmacotherapy in Disorders of Gut-Brain Interaction. Wei L; Singh R; Ghoshal UC J Neurogastroenterol Motil; 2022 Jul; 28(3):357-375. PubMed ID: 35719046 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]